Yuriz / iStockphoto.com
Dusa Pharmaceuticals, a subsidiary of India-based generic drug maker Sun Pharma, has accused dermatology-focused company Biofrontera of misappropriating trade secrets.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Sun Pharma, Dusa Pharmaceuticals, patent infringement, trade secret misappropriation, Biofrontera, dermatology
